Downloads
Abstract
Purposes: Surveying serum Gamma Glutamyl Transferase levels followed by the grade of heart failure patients (according to the New York Heart Association - NYHA) due to ischemic heart disease and evaluating the relationship between serum Gamma Glutamyl Transferase levels with Heart failure staging and laboratory tests (NT-proBNP levels, (EF) ejection fraction) in heart failure patients due to ischemic heart disease.
Method: Study design: a cross - sectional descriptive study, including 140 patients were treated at the Department of Cardiology, Hue Central Hospital, from March 1st, 2021, to May 30th, 2022. They were divided into two groups: the group with heart failure (n = 70) and the control group without heart failure (n = 70).
Result: The serum Gamma Glutamyl Transferase concentration increased significantly in the group of patients with heart failure (56 U/l) compared with the control group (34 U/l) (p < 0.05). The median value of serum Gamma Glutamyl Transferase concentrations in heart failure stages II, III, and IV in the study according to NYHA classification was 53 U/l, 56 U/l and 286 U/l, respectively. Serum Gamma Glutamyl Transferase levels were positively correlated with the severity of heart failure according to the NYHA class, (r = 0.49; p < 0.001). GGT had good value in predicting the severity of heart failure (AUC = 0.869; 95% CI: 0.767 - 0.938), the best cutoff GGT ≥ 51 U/l with sensitivity: 81.25%, specificity: 77.27%; Gamma Glutamyl Transferase concentration had a moderate positive correlation with NT-proBNP concentration (r = 0.42; p = 0.0004) and had a negative correlation with left ventricular ejection fraction (LVEF), (r = - 0.3; p = 0.013).
Conclusion: With a high diagnostic value, giving fast and accurate results of Gamma Glutamyl Transferase levels in various degrees of chronic heart failure, the Gamma Glutamyl Transferase test should be used as a good support test in the diagnosis and prognosis in patients with heart failure due to ischemic heart disease.
References
Pham Gia Khai, Nguyen Lan Viet et al, 2008 Recommendations on cardiovascular and metabolic diseases. 2008, Ho Chi Minh City: Medicine Publishing House
Huynh Van Minh. Postgraduate course- Cardiovascular pathology. 2003: Hue University of Medicine.
Nguyen Thi Phuong Mai. Evaluation of serum gamma glutamyl transferase activity of patients with some liver and biliary diseases at Hai Phong Medical University Hospital clinic. Medical Clinicl,. 2012;2807.
Brauwald E. Biomarker in Heart failure. N. Engl J Med. 2008;3582148-2159.
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(1):S15-S33.
McDonagh TA, Metra M, Adamo M, Gardner RS. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.
Poelzl G, Eberl C, Achrainer H, Doerler J. Prevalence and prognostic significance of elevated gammaglutamyltransferase in chronic heart failure. Circ Heart Fail. 2009;2(4):294-302.
Turgut O. , Yilmaz A. Gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Medical Hypotheses. 2006;671060-1064.
Wannamethee SG, Ebrahim S. Gamma glutamyl transferase: determinants and association with mortality from ischemic heart disease and all causes. The American Journal of Epidemiology. 1995;142699-708.
Emdin M, Passino C, Michelassi C, Donato L. Additive prognostic value of gammaglutamyltransferase in coronary artery disease. Int J Cardiol. 2009;136805.
Nguyen Thach, Some updated issues in the diagnosis and treatment of Cardiovascular Disease. 2007: Medical Publishing House.
Hoang Anh Tien. Study on diagnostic value of N-Terminal B-type Natriuretic Peptide (NT-ProBNP) concentration in acute exacerbation of chronic heart failure. 2006, Hue University of Medicine.
Franz H, Milton P, Andrew JS. Coats A. John Camm. NT-ProBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NTProBNP substudy. The European Journal of Heart Failure. 2003;6343-350.
| Published | 25-12-2024 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 92 (2023) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.92.7 | |
| Keywords | Gamma Glutamyl Transferase, heart failure, ischemic heart disease |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Clinical Medicine Hue Central Hospital